This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness ratios
Reference
Visconti AJ, et al. Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia.Journal of Gastroenterology and Hepatology : 22 Nov 2012. Available from: URL: http://dx.doi.org/10.1111/jgh.12041
Rights and permissions
About this article
Cite this article
Peginterferon-α-2a/ribavirin in HCV infection worth its cost. PharmacoEconomics & Outcomes News 669, 5 (2013). https://doi.org/10.1007/s40274-013-0050-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0050-1